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Abstract Donor age was identified recently äs a major factor
that determmes long-term outcome after transplantation, but
the mechanism that is responsible for increased graft loss of old
donor kidneys is unknown The influence of donor age on graft
survival was assessed retrospectively in 514 consecutive first
cadavenc transplants that were treated with cyclosporme mam-
tenance immunosuppression Donor age ^.50 yr (relative nsk
[RR] = l 7, 95% confidence mterval [CI], l 2 to 2 6), acute
rejection (RR = 20, 95% CI, l 3 to 3 0), and type of rejection
(RR = 33, 95% CI, 2 0 to 5 3) had a sigmficant impact on
graft survival However, when subsets of patients who entered
subsequent intervals after transplantation were analyzed, donor
age was not an independent predictive factor of graft loss
Donor age (RR = l 53, 95% CI, l 19 to l 98), human
leukocyte antigen-DR mismatch (RR = 2 28, 95% CI, l 78
to 2 92), and recipient age (RR = l 34, 95% CI, l 05 to
l 72) were associated sigmficantly with acute rejection ep-
isodes Delayed graft function alone was not associated
independently with the occurrence of early acute rejection
(RR = l 24, 95% CI, 0 96 to 161) The timmg of the
rejection episodes of old donor kidneys was not different,
and the excess rejection prevalence was attnbutable entirely
to interstitial (grade I) types of rejection Interstitial rejec-
tion episodes m kidneys from old donors had a sigmficant
(P < 0 05) negative impact on graft survival Beyond the
first year, poor renal function and protemuna were sigmfi-
cant nsk factors for graft loss, regardless of rejection Our
data fit best the hypothesis that increased graft loss of older
donor kidneys results from an increased incidence of acute
interstitial rejection episodes in the early posttransplantation
months It is proposed that kidneys from older donors are
more immunogemc than kidneys from young donors and
that acute rejection episodes result m functional detenora-
tion Contrary to interstitial rejection in kidneys from
younger donors, kidneys from old donors seem to have an
impaired abihty to restore tissue
The increasing gap between demand and availabihty of human
kidneys for transplantation has resulted in the use of non-heart-
beating donors and donors with an abnormal renal structure or
function, includmg donors who are older than 50 yr Between
1988 and 1995, there was a 172% increase in the number of
cadavenc donors who were older than 50 yr, which resulted in a
doublmg of the fraction of older donors from 12 to 25% (1) In
Eurotransplant, up to 25% of cadavenc transplants in 1998 came
from donors who were older than 55 yr (2)
The use of kidneys from old donors is associated with an
increased nsk of delayed graft function and an increased rate of
graft loss later on An analysis of 43,000 adult cadavenc
transplants revealed a higher prevalence of delayed graft func-
tion, increased need for postoperative dialysis treatments, and
a higher serum creatmine concentration at discharge in recip-
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icnts of old donor kidneys compared with patients who re-
ceived a kidney from a young donor (3) At 5-yr, there was a
25% difference in graft survival rate between transplants from
young and old donors, and the projected graft half-life de-
creased from 102 yr if the donor was between 16 to 20 yr of
age to 5 yr for grafts that came from donors who were 60 yr of
age Fmally, a number of investigators have reported on the
adverse effect of donor age on posttransplantation graft func-
tion (4,5), although not all centers found such an effect (6)
In a large multivanate analysis, donor age was identified äs the
most important factor that determines long-term outcome after
kidney transplantation (7) According to that analysis, 30% of
vanability in long-term outcome could be explained by donor age
However, not all vanables known to determine late graft loss,
such äs the acute rejection history, were mcluded in the analysis
The reason for the increased rate of graft loss is unknown The
present study was undertaken to examme factors that determine
the loss of kidney transplants from old donors
Materials and Methods
Patients
For the present study, all 663 consecutive first cadavenc renai
transplants that were performed m the Leiden Umversity Medical
Center between June 1983 and June 1997 were identified in our
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transplant database Only recipients who were treated with cyclospor-
me (CsA)-based immunosuppression (n = 514) were mcluded in the
present analysis Recipients who also received mycophenolate mofetil
were excluded The database contams donor variables (age at time of
death, gender, cause of death) and recipient variables (age at time of
transplantation, gender, original disease, panel reactive antibodies),
transplant factors (human leukocyte antigen-A [HLA-A], -B, and-DR
mismatches, cold ischemia time, warm ischemia time), and posttrans-
plantation features includmg immunosuppressive regimen, cyclospor-
me trough levels, delayed graft function, rejection history (time to first
acute rejection episode, nurnber of rejection episodes, histopathologic
type of rejection), dipstick protemuna, and renal function Kidneys
were allocated by Eurotransplant accordmg to a Standard algonthm on
the basis of matchmg for HLA We aimed to accept kidneys with no
more than two mismatches with a prionty for HLA-DR matchmg By
pohcy, kidneys from donors with known long-standing hypertension
or diabetes melhtus were not accepted for transplantation After
transplantation, patients were followed until death, return to dialysis,
or June l, 2000 Patient death with a functionmg graft was censored
äs a cause of graft loss Censonng non-renal-related deaths from the
assessment of long-term graft survival allows for more accurate
association of nsk factors and graft survival Eighteen patients (3 5%)
received a graft that never functioned because of thrombosis (n = 8),
tubular necrosis and severe vascular rejection (n = 5), bleeding (n =
2), undetected antibody-mediated rejection (n = 2), or mfection (n =
1) Pnmary nonfunction was found more often m kidneys from older
donors (7 7 versus l 9%, P < 0 005) These patients were excluded
from the study Delayed graft function was defined äs the need for
dialysis for at least 7 d posttransplantation The Standard immunosup-
pressive regimen consisted of prednisone and CsA and, in some
patients (n = 31), azathiopnne None of the patients received pro-
phylactic treatment with poly- or monoclonal antibodies The cumu-
lative incidence of acute rejection episodes in the first 6 mo was
57 5% and was confirmed by biopsy in 91 6% of the cases Graft
histology was evaluated retrospectively accordmg to the Banff '97
classification (8) Patients who had one or more rejection episode(s)
with artentis on biopsy were classified äs undergoing grade II rejec-
tion Acute rejection episodes were treated accordmg to a Standard
protocol consisting of methylpredmsolone l g mtravenously for three
consecutive days, a 10-d course of antithymocyte globuhn at a dose of
5 mg/kg guided by absolute lymphocyte counts, or agam methylpred-
msolone for the first, second (or steroid-resistant), or third rejection
episodes, respectively BP, number of antihypertensive drugs, dipstick
protemuna, serum creatimne, and endogenous creatimne clearance
(sequential 24-h collections) were collected at regulär mtervals
throughout the entire follow-up penod
Statistical Analyses
Charactenstics among groups were compared with the use of cross
tables with Fisher's exact tests and i tests for categoncal and contin-
uous variables, when appropnate Graft survival was estimated with
the use of Kaplan-Meier hfe tables and compared for the different
categones with the use of the Wilcoxon-Gehan lest The nsk for graft
loss in the different categones was analyzed with the use of Cox
regression Relevant factors for allograft loss in umvanate analysis
were fitted into a multivanate model All analyses were performed
with the use of the SPSS Statistical Software package (Version 9 0,
SPSS, Ine , Chicago, IL)
Results
In the total population (n = 496), overall graft survival was
91 8% at l yr and 83 6% at 5 yr after transpiantation Table l
shows that m both the univanate and the multivanate analysis,
donor age (relative nsk [RR] = l 72, 95% confidence mterval
[CI], l 15 to 2 58), acute rejection history (RR = l 95, 95% CI,
l 28 to 2 99), and the histologic pattern of rejection (RR =
3 26, 95% CI, 2 01 to 5 28) had a sigmficant impact on graft
survival Dunng the study penod, the donor age (mean ± SD)
mcreased sigmficantly from 39 0 ± 12 6 yr (1983 to 1986) and
40 3 ± 13 3 yr (1987 to 1992) to 42 7 ± 136 yr (1993 to
1997), but the proportion of donors who were 50 yr or older
was not sigmficantly different in these penods
The charactenstics of the study population grouped accord-
mg to donor age are summanzed in Table 2 In this cohort of
patients, there were no sigmficant differences between the two
groups with respect to the degree of histocompatibihty, grade
of sensitization, recipient age or gender, cold ischemia times,
and pretransplantation BP (Table 2) The majonty of older
donors were females, resulting in an mcreased female-donor-
to-male-recipient ratio in the old donor group Initial immuno-
suppression and average CsA trough levels at the time of
rejection and at follow-up (week 6, months 3 and 6, years l, 2,
and 5) were not different m recipients of kidneys from donors
who were 50 yr or older or who were younger than 50 yr The
cumulative incidence of acute rejection episodes in patients
who received a graft from a donor who was 50 yr or older was
sigmficantly higher (P < 0 005), whereas the timmg of the first
rejection episode was not different from rejections that oc-
curred in kidneys from younger donors (Figure 1) Histopatho-
logic analysis (Figure 2) showed that the mcrease m acute
rejection episodes in kidneys from older donors was attnbut-
able entirely to an mcrease m grade I or mterstitial type of
rejection episodes (P < 0 005) In the univanate analysis,
donor age >50 yr (RR = l 50, 95% CI, l 17 to l 94) and
delayed function (RR = l 36, 95% CI, l 05 to l 76) both were
associated with the occurrence of acute rejection episodes m
the first 6 posttransplantation months For further analysis, the
recipients were divided into four groups patients with donors
aged <50 yr and immediate graft function (group I, 50 1% of
patients), those with young donors but delayed graft function
(group II, 20 6%), recipients with donors ^50 yr and imme-
diate function (group III, 18 0%), and those with both older
donors and delayed function (group IV, 11 3%) The cumula-
tive incidence of acute rejection episodes grouped accordmg to
donor age and presence or absence of delayed graft function is
plotted in Figure 3 The nsk of acute rejection episodes was
sigmficantly higher in kidneys from older donors with imme-
diate function (group III RR = l 68, 95% CI, l 21 to 2 35)
and those with delayed function (group II RR = l 40, 95% CI,
l 01 to l 94, group IV RR = l 76, 95% CI, l 20 to 2 56) In
the multivanate model (Table 3), delayed graft function per se
was not a sigmficant nsk factor for acute rejection (RR = l 24,
95% CI, 0 96 to l 61) In contrast, HLA-DR mismatch > l (RR
= 2 28, 95% CI, l 78 to 2 92), donor age >50 yr (RR = I 53,
95% CI, l 19 to l 98), recipient age <50 yr (RR = l 34, 95%
CI, l 05 to l 72), and total number of mismatches (RR = l 27,
95% CI, l 14 to l 43) were associated sigmficantly with acute
rejection episodes The mcrease in acute rejection episodes of
old donor kidneys was higher both m recipients ä50 yr (P <
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a RR, relative nsk, CI, confidence interval, HLA, human leukocyte antigen
b P < 0 05
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0 05) and m younger patients (P < 001, Figure 4) The
requirement for antithymocyte globulm to treat acute rejection
episodes was not sigmficantly (P = 0 21) different in recipi-
ents of kidneys from older donors compared with patients with
younger donors
The number of recipients available for evaluation at 1,5, and
10 yr after transplantation was 418, 291, and 115, respectively
The percentage of these patients that received a kidney from a
donor who was 50 yr or older was 27%, 25 4%, and 19 1%,
respectively Survival accordmg to acute rejection history m
relation to donor age is shown in Figure 5 In patients without
an acute rejection episode, there was no effect of donor age on
graft survival, but a sigmficantly increased (P < 0 02) rate of
graft loss occurred in patients with old donor kidneys and a
history of acute rejection To estimate short- and long-term
effects of donor age, the posttransplantation time was parti-
tioned mto consecutive intervals, and subsets of patients who
entered each interval were analyzed The umvanate analysis
(Table 4) for graft loss in the first year after transplantation
identified donor age (RR = l 94, 95% CI, l 03 to 3 65),
recipient age (RR = 2 04, 95% CI, l 07 to 3 89), recipient
gender, and acute rejection episode(s) (RR = 738, 95% CI,
2 62 to 20 76) äs sigmficant nsk factors Table 5 shows the
mdependent nsk factors for graft loss in the multivanate anal-
ysis In the multivanate model, donor age was not associated
independently with graft loss in the first posttransplantation
year (RR = l 69, 95% CI, 0 89 to 3 19) Survival accordmg to
donor age in relation to histologic type of acute rejection is
plotted m Figure 6 These data mdicated that acute interstitial
(grade I) rejection episodes m recipients of kidneys from
donors who were older than 50 yr have a powerful negative
impact on graft survival
Beyond l yr, three factors were associated with graft loss in
the umvanate analysis (Table 4) a suboptimal graft function at
l yr, defined äs creatimne clearance of 30 to 50 ml/mm (RR =
251, 95% CI, l 40 to 4 51) or less than 30 ml/mm (RR = 7 25,
95% CI, 3 59 to 14 6), protemuna (RR = 4 16, 95% CI, 2 36
to 7 33), and donor age (RR = l 77, 95% CI, l 06 to 2 96) In
the multivanate analysis (Table 6), donor age was not associ-
ated sigmficantly with graft loss beyond the first year (RR =
l 50, 95% CI, 0 88 to 2 58) or beyond 5 yr (RR = l 38, 95%
CI, 061 to 3 14) Poor renal function was a sigmficant nsk
regardless of rejection at l and 5 yr, äs was protemuna
Discussion
In the present study, we analyzed the interaction between
age and acute rejection The pnncipal finding is that kidneys
from older donors are more hkely to undergo acute rejection
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Table 2. Characteristics of study population grouped according to donor agea
Characteristic
Donor Age
<50 yr (n = 352) >50 yr (n = 144)
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cold ischemia time (h)










BP (MAP; mmHg) at 1 yr
creatinine clearance (ml/min) at 1 yr
proteinuria > 1 + (%) at 1 yr
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Figure 1. Cumulative incidence of first acute rejection episodes ac-
cording to donor age in first cadaveric renal transplants.
episodes in the early posttransplantation period compared with
kidneys from younger donors. An increased frequency of acute
rejection episodes in kidneys from older donors was noted
< 50 yr. (n=352) > 50 yr. (n=l 44)
Donor Age
Figure 2. Histopathologic type of acute rejection episodes according
to donor age. E3, clinical; D, grade II; ·, grade I.
previously (9). In our patients, the increased incidence of acute
rejection was not related to factors such äs recipient age or
delayed graft function, and the timing of the first rejection
episodes was not different from the rejections that occurred in
kidneys from younger donors. Analysis of the histopathologic
rejection pattern revealed that the increased acute rejection rate
was attributable entirely to an increased prevalence in the
interstitial types of rejection episodes and not the vascular
rejection type. Finally, when we analyzed the impact of ad-
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Figure 3. Cuniulative incidence of first acute rejection episodes ac-
cording to donor age and presence or absence of delayed graft
function.
vanced donor age on graft survival, a significantly increased
rate of graft loss of kidneys from older donors was observed
only in the group of patients who had experienced acute
rejection episodes. The adverse outcome in this group of pa-
tients occurred in the first 5 yr posttransplantation, whereas
there was no significant difference beyond 5 yr. Our results
suggest that older donor kidneys are more immunogenic than
kidneys from young donors and that the prognostic impact of
an acute interstitial rejection episode is worse in older kidneys.
Thus, the effect may be attributable to an interaction between
changes of renal aging and the immune response.
Our results are at variance with the results from other stud-
ies. Moreso et al. (10) observed increased graft loss of kidneys
from old donors when such kidneys experienced acute rejec-
tion or delayed graft function without acute rejection. In a
time-dependent analysis of risk factors for graft loss, Prom-
mool et al. (11) found that delayed graft function and acute
rejection were risk factors for graft loss in the first 5 yr but
thereafter donor age seemed to be the most important factor.
Both studies differed from ours in that prophylactic treatment
with antilymphocyte antibodies was administered to a substan-
tial fraction of patients. In addition, in the latter study, delayed
graft function was defined äs the need for dialysis during the
first 2 posttransplantation weeks, and only rejections that re-
quired antibody therapy were considered (l 1). It is conceivable
that early and potent immunosuppression attenuates the inter-
action between renal aging changes, ischemia-reperfusion in-
jury, and the immune response. Acute rejection episodes have
an adverse impact on renal allograft outcome (12). In the chain
of events that lead to acute rejection and late graft loss, delayed
graft function has been proposed to play a role (13,14). In a
Risk Factor RR 95% CI P Value
Cold ischemia time (per h)
Delayed graft fiinction
HLA-DR mismatch (>1)
Donor age (s 50 yr)
















previous study (15), we showed that delayed graft function is
one of several risk factors of acute rejection and suboptimal
function at l yr, but it was not associated independently with
an increased rate of graft loss within the first posttransplanta-
tion year. In the present study, we confirmed that delayed graft
function alone had no impact on long-term outcome and found
that it was not associated independently with an increased
incidence of acute rejection episodes in the first posttransplan-
tation months.
Kidneys from older individuals have several structural and
functional changes compared with kidneys from younger do-
nors. Longitudinal studies of elderly individuals have shown a
diminution in renal reserve, along with functional constraints
on the kidney's ability to respond appropriately to challenges
of either excesses or deficits (16). Studies of kidneys obtained
at autopsies demonstrated a progressive decrease in the number
and size of glomeruli with age, resulting in a progressive
decrease of the glomerular filtration volume (17,18). In addi-
tion to the loss of glomeruli, there is an age-dependent increase
in the cortical interstitial volume äs a result of progressive
interstitial fibrosis (18,19). Most renal biopsies from kidney
donors who are older than 40 yr show intimal fibrosis in the
smaller arteries, arteriolar hyalinosis, and interstitial fibrosis
(20).





Figure 4. Prevalence of acute rejection episodes according to donor
and recipient age.























Years post-transplant Years post-transplant
Figure 5. Kidney graft survival according to acute rejection history and donor age in first cadaveric transplants: (A) no rejection; (B) acute
rejection.
kidneys have fewer nephrons that function adequately and that
the summation of insults and damage results in an early demise
of the graft. It also has been proposed that graft parenchymal
cells undergo premature senescence or aging äs a result of
multiple injuries and repair (21). If progressive loss of renal
mass or senescence is the mechanism of increased graft loss,
then it is expected that grafts from older donors show a
progressive decrease of graft survival with time and that the
rate of decline of graft function correlates with donor age. Our
fmding that increased graft loss occurs predominantly in the
first 5 posttransplantation years does not support this proposal.
Similarly, Kasiske (6) also found no effect of donor age on the
rate of decline in graft function between l yr and last
follow-up.
Our clinical data suggest that the loss of older donor kidneys
is related to an increased incidence of acute rejection episodes
in the first few posttransplantation months. The correlation
between acute rejection episodes and impaired long-tera out-
come is well established and often is reported äs rejection-
related decreases in projected graft half-lives (22). The use of
the half-lives concept suggests that an early rejection episode
constitutes a continuous risk for graft failure throughout the
remaining time of the graft. However, inspection of graft
survival curves show that the increased graft loss in the group
with acute vascular rejection occurs only in the first few
posttransplantation years (23). Modeling of the risk of graft
loss over time äs a function of the number of rejection episodes
demonstrates that the risk of graft loss related to rejection is
greatest in the early posttransplantation period (24). In patients
with no acute rejection episodes, the risk of graft loss de-
creased sharply at a few months posttransplantation and at 2 yr
reached a low level. Patients with a single rejection episode
reached the same low-level graft loss at 3 to 4 yr, whereas for
patients with multiple rejection episodes, the risk of graft loss
was several times that of the other patients up to 6 yr post-
transplantation, at which point it also stabilized at a relatively
low level. Thus, our data fit best the hypothesis that increased
graft loss of older donor kidneys results from an increased graft
loss related to an increased incidence of acute rejection epi-
sodes in the early posttransplantation months. We therefore
propose that kidneys from older donors are more immunogenic
than kidneys from younger donors.
Our data are very similar to those of Kerr et al. (25), who
demonstrated that old donor age or the presence of one or more
acute rejection episodes are the only factors that are associated
with decreased death-censored graft survival. Of interest is the
observation that in living donor transplants, only occurrence of
an acute rejection episode and not donor age per se is associ-
ated independently with decreased graft survival (25). Grafts
from older donors may already have tissue inflammation at the
time of procurement and transplantation, which in turn may
increase immune recognition. A variety of types of injury elicit'
a cascade of inflammatory events that contribute to a general
stereotyped response to tissue injury, the injury response (26).
In general, antigens that are expressed in normal tissue tend to
be ignored, whereas antigens that are expressed in injured
tissue are more likely to provoke and activate an immune
response (27). The increased immunogenicity may be ex-
plained by the presence of proinflammatory cytokines, in-
creased expression of major histocompatibility complex anti-
gens in epithelial and endothelial cells, and the recruitment and
activation of antigen-presenting cells (28-30). Injury related to
the process of transplantation thus can favor rejection, and
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Table 4. Risk factors of graft loss in the first year and beyond year l and year 5 according to the univariate analysis
Risk Factor
First Year Beyond l Yr Beyond 5 Yr
RR 95% CI RR 95% CI RR 95% CI
Pretransplantation factors
HLA mismatch ,' ·
A-B-DR 1.24 ~-··-0,94-1.64 1.05 0.86-1.31 1.28 0.90-1.81
A-B 1.31 0.95-1.81 1.03 0.80-1.33 1.22 0.82-1.83
DR 1.07 0.60-1.91 1.17 0.75-1.83 1.48 0.80-2.77
panel reactive antibodies (>50%) ' 1.88 0.89-3.95 0.75 0.37-1.53 0.82 0.31-2.18
gender
donor (female) 1.28 0.68-2.39 1.03 0.62-1.69 1.57 0.75-3.30
recipient (female) 1.86a 1.01-3.49 0.88 0.52-1.49 1.13 0.53-2.41
mismatch: female to male 0.96 0.47-1.97 1.29 0.75-2.21 1.75 0.81-3.81
cold ischemia time (h) 1.00 0.95-1.05 1.00 0.96-1.04 0.94 0.88-1.05
age
recipient (SSO yr) 2.04a 1.07-3.89 0.73 0.43-1.23 1.08 0.50-2.30
donor (>50yr) 1.94a 1.03-3.65 1.77a 1.06-2.96 1.66 0.75-3.68
Posttransplantation factors
initial immunosuppression (dual) 0.42 0.06-3.06 0.64 0.31-1.53 0.76 0.26-2.24
delayed graft function 1.36 0.70-2.63 0.64 0.72-2.08 1.14 0.52-2.53
acute rejection episode(s) 7.38C 2.62-20.8 1.28 0.77-2.11 1.11 0.52-2.35
type of rejection
no rejection 1.00 1.00 1.00
grade l 3.7Γ 1.20-11.5 1.18 0.67-2.06 0.98 0.41-2.35
grade 2 15.4C 5.30-44.4 1.50 0.76-2.95 1.38 0.50-3.83



















a / > < 0.05.
bP < 0.005.
c P < 0.0001.
rejection-related injury in turn may induce inflammation and uated immune responses and a reduced life expectancy, it has
new immune activation—the injury triangle. been proposed that kidneys frorn older donors should be allo-
On the basis of the assumption that old patients have atten- cate to old recipients. Our data indicate that such kidneys are
Table 5. Risk factors of graft loss in various time periods according to the multivariate analysis
Risk Factor
Overall First Year Beyond l Yr Beyond 5 Yr
RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Pretransplantation factors
donor age (>50 yr) 1.72a 1.15-2.58 1.69
recipient
age(>50yr) 1.16 0.75-1.72 2.27a
gender (female) 1.31 0.88-1.95 2.22a
Posttransplantation factors
acute rejection episode(s) 2.02b 1.32-3.10 7.91C
type of acute rejection



































a P < 0.05.
bP < 0.005.
°P < 0.0001.
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Figure 6. Kidney graft survival according to donor age and histopathologic type of acute rejection in first cadaveric transplants: (A) donor age
<50 yr; (B) donor age S50 yr.
Table 6. Risk factors of graft loss beyond the first year: multivariate analysis















































more immunogenic and therefore may require more intense
immunosuppression of the recipient, irrespective of age. Al-
though such an approach may be acceptable for recipients who
are younger than 50 yr, it remains to be seen that this is safe for
substantially older recipients, i.e., those older than 60 or 65 yr.
However, reduction in acute rejection episodes with more
immunosuppression does not necessarily result in improved
graft survival (31).
The alternative possibility is that the increased incidence
of acute rejection episodes is a marker for the biology of the
organ. It is conceivable that the old kidneys with acute
rejection are different from the old kidneys that do not
reject. The finding that approximately one third of the
patients who were included in the Baltimore Longitudinal
Study of Aging (32) did not show any change in the GFR
and the existence of rat strains that do not develop any
aging-related renal damage (33) suggest that the renal dys-
function of the elderly may be due to an accumulation of
damage induced by minimal, clinically undetected renal
disease and is not the consequence of the aging process
itself. We suggest that kidneys with more aging-related
damage or older kidneys of poorer quality are more immu-.
nogenic, which results in an increased incidence of acute
interstitial rejection. Contrary to interstitial rejection in kid-
neys from younger donors, kidneys from old donors seem to
have an impaired ability to restore tissue.
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